MEDREH · EP 05 · TRANSPLANT
Before You Listen
Episode Setup
- Topic in one line: the altered physiology, immunosuppression-driven musculoskeletal complications, and organ-specific exercise prescription rules for heart, lung, liver, kidney, and bone marrow transplant recipients on the American Board of Physical Medicine and Rehabilitation (ABPMR) Part I examination.
- Prerequisites: baseline cardiac autonomic physiology (vagal tone, sympathetic drive), pulmonary mucociliary clearance and the cough reflex, hepatic and renal metabolism, the Karvonen heart rate (HR) reserve formula, the rating of perceived exertion (RPE) Borg 6-20 scale, and steroid pharmacology.
- Runtime: 1 hour 2 minutes.
Vignette. A 64-year-old man is 4 months post orthotopic heart transplantation for ischemic cardiomyopathy and presents to phase II cardiac rehabilitation. His resting HR is 102 beats per minute (bpm) on the ECG monitor. He reports no chest pain. The therapist sets a Karvonen-derived target HR of 130 bpm. Within 90 seconds of treadmill walking the patient reports light-headedness, his HR is still 104, and his blood pressure (BP) drops from 124/72 to 96/58. After 6 minutes of low-grade walking his HR climbs to 128. His daily medications include tacrolimus, mycophenolate mofetil, prednisone 15 mg, atorvastatin, and aspirin. A recent dual-energy x-ray absorptiometry (DEXA) showed a femoral neck T-score of -2.7.
Why does the Karvonen formula fail in this patient, what method should the therapist use to set intensity, what extended warm-up duration is appropriate, what is the most likely explanation for his low T-score, and what single class of medication should be reviewed before initiating high-impact exercise?
(Answer at the end of this chapter)
Section 1: Heart Transplant — The Denervated Heart and Cardiac Allograft Vasculopathy
Bottom line: surgical denervation severs both vagal and sympathetic fibers to the donor heart, which raises the resting HR to approximately 90-110 bpm (loss of vagal brake), delays the exercise HR response by 2-5 minutes (because rate now depends on circulating catecholamines rather than direct neural drive), blunts the peak HR to roughly 70-80 percent of age-predicted maximum, and prolongs HR recovery for 5-10 minutes after exercise; therefore the Karvonen formula is unreliable, and intensity is prescribed by the Borg RPE 6-20 scale targeting 11-14 with extended 10-15 minute warm-up and cool-down windows; cardiac allograft vasculopathy is diffuse concentric coronary intimal hyperplasia representing chronic rejection, presents as silent ischemia because the denervated heart cannot generate angina, and requires annual surveillance angiography or intravascular ultrasound.
The transplanted heart is denervated at the time of orthotopic implantation. Both the parasympathetic vagal fibers and the sympathetic postganglionic fibers to the donor heart are transected, and reinnervation, when it occurs, is partial, delayed, and unpredictable. The clinical signature of denervation is a constellation of four predictable autonomic findings that drive the entire exercise prescription.
The resting HR is elevated to approximately 90-110 bpm because the sinoatrial node, freed from tonic vagal inhibition, reverts toward its intrinsic firing rate of about 100 bpm. This is not pathologic in the recipient and is not a sign of rejection or volume depletion; it is the expected physiology of denervation. The HR response to exercise onset is delayed by 2-5 minutes because the rapid neural acceleration normally produced by vagal withdrawal and sympathetic activation is unavailable. Rate increase now depends on circulating epinephrine released from the adrenal medulla and norepinephrine spillover from sympathetic terminals elsewhere in the body. Catecholamines must be released, traverse the bloodstream, and bind beta-adrenergic receptors on the donor sinoatrial node before HR rises. The peak HR is blunted to approximately 70-80 percent of the age-predicted maximum because humoral acceleration cannot match neural drive. The HR recovery is prolonged: instead of the rapid drop produced by vagal reactivation, HR remains elevated for 5-10 minutes until catecholamines are cleared.
These four findings dictate the exercise prescription. The Karvonen formula (target HR equals resting HR plus a percentage of HR reserve, where HR reserve equals maximum HR minus resting HR) fails because both the resting and peak HR values are abnormal and the relationship between HR and workload is non-linear during the catecholamine ramp-up. Use the Borg RPE 6-20 scale with a target of 11-14 (fairly light to somewhat hard). Extend the warm-up to 10-15 minutes so circulating catecholamines have time to rise and meet workload before the patient reaches target intensity, and extend the cool-down to 10-15 minutes to prevent post-exercise hypotension as catecholamines decline.
Figure 5.2 — Denervated heart HR response curve: graph showing HR (y-axis, bpm) vs time (x-axis, minutes) during exercise onset, comparing innervated heart (rapid neural acceleration within seconds) vs denervated transplanted heart (delayed catecholamine-driven 2-5 minute ramp-up to peak 70-80% age-predicted, then prolonged 5-10 minute recovery). Source needed: open-source physiology graph or cardiac transplant rehabilitation reference figure illustrating exercise HR kinetics in denervated heart.
Mnemonic — “Five and Fifteen” for the denervated heart
5 percent the catecholamines have to ramp before HR rises (delayed onset, 5 minutes). 15 minutes warm-up and 15 minutes cool-down. HR target: forget the formula, trust the talk test at Borg 11-14.
Cardiac allograft vasculopathy (CAV) is the leading cause of late mortality after heart transplantation and represents chronic rejection of the coronary vasculature. Unlike typical atherosclerotic coronary artery disease, which is focal, eccentric, and confined to proximal epicardial segments, CAV produces diffuse, concentric intimal hyperplasia that involves the entire coronary tree from large epicardial vessels down to small intramyocardial branches. The diffuse pattern makes CAV poorly amenable to percutaneous intervention or surgical bypass, and surveillance is performed annually by coronary angiography or intravascular ultrasound (IVUS).
The single most important rehabilitation point about CAV is that it presents as silent ischemia because the denervated heart has no sensory afferents to generate angina. Patients do not experience chest pain. The first manifestation may be unexplained heart failure, new arrhythmia, declining exercise tolerance during therapy sessions, or sudden cardiac death. Rehabilitation staff must be vigilant for any unexplained drop in workload tolerance, new dyspnea at previously tolerated levels, fatigue out of proportion to activity, or new lower-extremity edema. Document the baseline exercise capacity carefully so a decline can be recognized.
High Yield — Heart transplant rehab
- Resting HR 90-110 bpm, exercise onset delayed 2-5 min, peak HR 70-80% of age-predicted, recovery prolonged 5-10 min.
- Karvonen FAILS in cardiac transplant — use Borg RPE 11-14.
- Warm-up and cool-down both extended to 10-15 minutes.
- Cardiac allograft vasculopathy = diffuse concentric intimal hyperplasia, chronic rejection; presents as silent ischemia (denervated heart cannot generate angina); surveillance with annual angiography or intravascular ultrasound.
- Partial reinnervation is variable and unpredictable; do not assume it.
That is why the resting heart rate of a denervated heart stays elevated at 90 to 110 beats per minute. A therapist takes the patient’s pulse, sees it sitting at 100 beats per minute while the patient is just sitting in a chair, and panics. They might think, oh, they’re tachycardic. They are having an arrhythmia. I need to hold therapy.
— MEDREH-05 podcast, ~05:23